Search Results - "Annals of surgical oncology"
-
1
GLOBOCAN 2020 Report on Global Cancer Burden: Challenges and Opportunities for Surgical Oncologists
Published in Annals of surgical oncology (01-10-2022)“…Cancer is emerging as a major public health challenge globally. Recently, IARC (International Association of Research on Cancer) published global cancer burden…”
Get full text
Journal Article -
2
AJCC 8th Edition: Colorectal Cancer
Published in Annals of surgical oncology (01-06-2018)Get full text
Journal Article -
3
8th Edition of the AJCC Cancer Staging Manual: Pancreas and Hepatobiliary Cancers
Published in Annals of surgical oncology (01-04-2018)Get full text
Journal Article -
4
Eighth Edition of the AJCC Cancer Staging Manual: Breast Cancer
Published in Annals of surgical oncology (01-07-2018)Get full text
Journal Article -
5
Prognostic and Therapeutic Implications of Microvascular Invasion in Hepatocellular Carcinoma
Published in Annals of surgical oncology (01-05-2019)“…Hepatocellular carcinoma (HCC) is a morbid condition for which surgical and ablative therapy are the only options for cure. Nonetheless, over half of patients…”
Get full text
Journal Article -
6
Incident Cases Captured in the National Cancer Database Compared with Those in U.S. Population Based Central Cancer Registries in 2012–2014
Published in Annals of surgical oncology (01-06-2019)“…Background The National Cancer Database (NCDB) is a hospital-based cancer registry that includes diagnostic, staging, treatment, and outcomes data for newly…”
Get full text
Journal Article -
7
Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond
Published in Annals of surgical oncology (01-08-2018)Get full text
Journal Article -
8
Randomized Trial Comparing Resection of Primary Tumor with No Surgery in Stage IV Breast Cancer at Presentation: Protocol MF07-01
Published in Annals of surgical oncology (01-10-2018)“…Background The MF07-01 trial is a multicenter, phase III, randomized, controlled study comparing locoregional treatment (LRT) followed by systemic therapy (ST)…”
Get full text
Journal Article -
9
Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: An Updated Consensus Approach from the Transatlantic Australasian RPS Working Group
Published in Annals of surgical oncology (01-11-2021)“…Background Retroperitoneal soft tissue sarcomas comprise a heterogeneous group of rare tumors of mesenchymal origin that include several well-defined…”
Get full text
Journal Article -
10
Management of Cancer Surgery Cases During the COVID-19 Pandemic: Considerations
Published in Annals of surgical oncology (01-06-2020)Get full text
Journal Article -
11
Consensus Guidelines on Genetic` Testing for Hereditary Breast Cancer from the American Society of Breast Surgeons
Published in Annals of surgical oncology (01-10-2019)“…Background The purpose of this consensus guideline is to outline recommendations for genetic testing that medical professionals can use to assess hereditary…”
Get full text
Journal Article -
12
Analysis of Prognostic Factors from 9387 Merkel Cell Carcinoma Cases Forms the Basis for the New 8th Edition AJCC Staging System
Published in Annals of surgical oncology (01-10-2016)“…Background The first consensus Merkel cell carcinoma (MCC) staging system was published in 2010. New information on the clinical course prompts review of MCC…”
Get full text
Journal Article -
13
Validation of the 8th Edition of the AJCC TNM Staging System for Gastric Cancer using the National Cancer Database
Published in Annals of surgical oncology (01-11-2017)“…Background The 8th edition AJCC gastric cancer staging manual was refined using Japanese and Korean data from the International Gastric Cancer Association…”
Get full text
Journal Article -
14
Prognostic Significance of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Oncologic Outcomes of Esophageal Cancer: A Systematic Review and Meta-analysis
Published in Annals of surgical oncology (01-02-2016)“…Background Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) have been reported to predict oncologic outcomes in patients with…”
Get full text
Journal Article -
15
Prognosis After Resection of Barcelona Clinic Liver Cancer (BCLC) Stage 0, A, and B Hepatocellular Carcinoma: A Comprehensive Assessment of the Current BCLC Classification
Published in Annals of surgical oncology (01-10-2019)“…Background Although the Barcelona Clinic Liver Cancer (BCLC) staging system has been largely adopted in clinical practice, recent studies have questioned the…”
Get full text
Journal Article -
16
How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study
Published in Annals of surgical oncology (01-10-2016)“…Background In breast cancer patients with nodal metastases at presentation, false-negative rates lower than 10 % have been demonstrated for sentinel node…”
Get full text
Journal Article -
17
Exosomal PD-L1 Retains Immunosuppressive Activity and is Associated with Gastric Cancer Prognosis
Published in Annals of surgical oncology (01-10-2019)“…Background A recent study showed that circulating exosomal PD-L1 is an effective predictor for anti-PD-1 therapy in melanomas. Exosomal PD-L1 induced…”
Get full text
Journal Article -
18
TOPGEAR: A Randomized, Phase III Trial of Perioperative ECF Chemotherapy with or Without Preoperative Chemoradiation for Resectable Gastric Cancer: Interim Results from an International, Intergroup Trial of the AGITG, TROG, EORTC and CCTG
Published in Annals of surgical oncology (01-08-2017)“…Background Postoperative chemoradiation and perioperative chemotherapy using epirubicin/cisplatin/5-fluorouracil (ECF) represent two standards of care for…”
Get full text
Journal Article -
19
Validation of the American Joint Commission on Cancer (AJCC) 8th Edition Staging System for Patients with Pancreatic Adenocarcinoma: A Surveillance, Epidemiology and End Results (SEER) Analysis
Published in Annals of surgical oncology (01-07-2017)“…Background The 8th edition of the AJCC staging system for pancreatic cancer incorporated several significant changes. This study sought to evaluate this…”
Get full text
Journal Article -
20
Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial
Published in Annals of surgical oncology (01-12-2016)“…Purpose Talimogene laherparepvec (T-VEC) is an oncolytic immunotherapy designed to induce tumor regression of injected lesions through direct lytic effects,…”
Get full text
Journal Article